Medchemfarma: Acció 2023
Medchemfarna has been beneficiary in the call for start-up capital grants for emerging technology companies for the year 2023, through Acciò Program (https://accio.gencat.cat) to carry out the...
Making innovative medicine available for patients suffering devastating autoimmune diseases.
How do we achieve our vision
Medchemfarma focused internal resources on areas where lies the experience of the management team:
Medchemfarna has been beneficiary in the call for start-up capital grants for emerging technology companies for the year 2023, through Acciò Program (https://accio.gencat.cat) to carry out the...
Medchemfarna has got access to funds through the support of the Ministerio de Ciencia, Innovación y Universidades, Next Generation EU funds and from the Recovery, Transformation and Resilience...